Jennison Associates’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-582,120
Closed -$33.1M 717
2021
Q2
$33.1M Buy
582,120
+22,594
+4% +$1.28M 0.02% 295
2021
Q1
$41.9M Sell
559,526
-4,442
-0.8% -$332K 0.03% 244
2020
Q4
$48.8M Buy
563,968
+125,603
+29% +$10.9M 0.03% 207
2020
Q3
$26.8M Buy
438,365
+220,127
+101% +$13.5M 0.02% 273
2020
Q2
$9.07M Buy
218,238
+571
+0.3% +$23.7K 0.01% 383
2020
Q1
$6.25M Sell
217,667
-213,542
-50% -$6.13M 0.01% 373
2019
Q4
$31.1M Sell
431,209
-2,412,480
-85% -$174M 0.03% 251
2019
Q3
$399M Sell
2,843,689
-110,224
-4% -$15.5M 0.42% 48
2019
Q2
$541M Buy
2,953,913
+598,299
+25% +$110M 0.54% 44
2019
Q1
$375M Buy
2,355,614
+1,509,950
+179% +$240M 0.37% 49
2018
Q4
$81M Buy
845,664
+35,440
+4% +$3.39M 0.09% 130
2018
Q3
$114M Buy
810,224
+4,863
+0.6% +$687K 0.11% 121
2018
Q2
$126M Buy
805,361
+14,338
+2% +$2.24M 0.12% 116
2018
Q1
$127M Buy
791,023
+112,316
+17% +$18.1M 0.13% 114
2017
Q4
$112M Sell
678,707
-195,043
-22% -$32.1M 0.11% 134
2017
Q3
$54.4M Sell
873,750
-215,778
-20% -$13.4M 0.06% 257
2017
Q2
$86.8M Buy
1,089,528
+4,806
+0.4% +$383K 0.09% 175
2017
Q1
$77.1M Buy
1,084,722
+256,247
+31% +$18.2M 0.08% 203
2016
Q4
$42.3M Buy
828,475
+2,731
+0.3% +$139K 0.05% 292
2016
Q3
$38M Buy
825,744
+392,333
+91% +$18.1M 0.04% 317
2016
Q2
$13.1M Buy
433,411
+1,866
+0.4% +$56.2K 0.01% 439
2016
Q1
$13.8M Buy
431,545
+176,400
+69% +$5.66M 0.01% 435
2015
Q4
$14.9M Buy
+255,145
New +$14.9M 0.01% 446